Roberto Guerciolini

This profile gathers the share dealings of Roberto Guerciolini across 2 companies, led by Wave Life Sciences Ltd. and Sirna Therapeutics Inc. The record holds 6 filings, for trades running from 21 February 2006 to 7 December 2016.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

On 9 December 2016 came the latest disclosure, an option exercise for €46k in Wave Life Sciences Ltd. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.